In the US, Hytrin (terazosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia, High Blood Pressure and Hyperhidrosis.
Ingredient matches for Hytrin
Terazosin is reported as an ingredient of Hytrin in the following countries:
- South Africa
- United States
Terazosin hydrochloride dihydrate (a derivative of Terazosin) is reported as an ingredient of Hytrin in the following countries:
- Czech Republic
- Hong Kong
- New Zealand
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.